What is Autoinjectors?


 

Autoinjectors Market By Product Type (Disposable And Reusable), By Type (Prefilled And Fillable), By Portability (Handheld And Wearable), By Indication (Rheumatoid Arthritis, Diabetes, Anaphylaxis, Multiple Sclerosis, And Others), By End User (Hospitals, Clinics, And Homecare Settings), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. 

Global Autoinjectors Market was valued at USD 1.80 billion in 2020, growing at a CAGR of 20.50% during the forecast period from 2021 to 2026 to reach USD 5.51 billion by 2026. The demand for autoinjectors is witnessing growth due to the number of indications requiring immediate and emergency administration of interventional drugs such as anaphylaxis and multiple sclerosis, allows for self-administration of drugs, offers a safe alternative to conventional syringes, and the favorable reimbursement programs for these procedures.

What is the Autoinjectors Market Insights?

The autoinjectors market is estimated to register significant growth in the forecast period on account of growing need for emergency administration of therapeutic drugs. As per the data provided by the Multiple Sclerosis International Federation, Atlas of MS, 3rd Edition, in 2020, the estimates of number of people living with MS worldwide has increased to 2.8 million in 2020. The estimates presented a 30% increase from 2013 data. The 2020 global prevalence is 35.9 per 100,000 people. Multiple sclerosis (MS) is a debilitating indication which usually presents at a highly productive stage of life and can massively impact the quality of life of patients.  Even though there is no specific cure for the indication at present for the treatment of MS, many therapies such as AVONEX Pens are available in the market that help in controlling clinical exacerbations associated with MS.

Original Source:- Autoinjectors Competitive Landscape

Comments